Profile
Sector:
Consumer DefensiveIndustry:
Household & Personal ProductsCountry:
United StatesIPO:
17 March 1980Website:
http://www.u-g.comNext earnings report:
21 March 2025Last dividends:
23 July 2024Next dividends:
N/APrice
after hours | Thu, 21 Nov 2024 21:00:09 GMTAnalysts recommendations
Institutional Ownership
UG Latest News
UG's Q3 earnings gain from effective cost management and increased demand for its cosmetic ingredients segment.
HAUPPAUGE, N.Y., Nov. 08, 2024 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the third quarter and the first nine months of 2024. Sales for the nine-month period ended September 30th increased from $8,278,141 in 2023 to $9,705,262 in 2024 and net income increased from $1,843,931 ($0.40 per share) to $2,747,151 ($0.60 per share) for the same period. The third quarter remained steady with sales of $3,057,518 in 2023 and $3,060,113 in 2024, while net income increased from $626,756 ($0.14 per share) to $865,484 ($0.19 per share).
Higher cosmetic ingredient sales aid United-Guardian's (UG) earnings in Q2.
HAUPPAUGE, N.Y., Aug. 09, 2024 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the second quarter and first half of 2024. Sales for the six-month period ended June 30th increased from $5,220,623 in 2023 to $6,645,149 in 2024 and net income increased from $1,217,175 ($0.26 per share) to $1,881,667 ($0.41 per share) for the same period. Second quarter sales increased from $2,650,299 in 2023 to $3,390,205 in 2024, with net income increasing from $461,094 ($0.10 per share) to $956,225 ($0.21 per share).
HAUPPAUGE, N.Y., July 12, 2024 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today that the company's Board of Directors, at its meeting on July 10, 2024, declared a cash dividend of $0.35 per share, to be paid on July 31, 2024, to all stockholders of record as of the close of business on July 23, 2024. This will be the 29th consecutive year that the company has paid a dividend.
Discover why Zacks rates United-Guardian (UG) as "Outperform," being the first on Wall Street to initiate the coverage of the stock. Explore UG's robust growth in cosmetic ingredient sales, a strong financial foundation and promising product launches, making it an attractive option for investors.
Volumes are currently depressed due to a stronger dollar, a slow Chinese reopening, and customer destocking. The company is highly profitable as it has very high profit margins. The balance sheet is robust thanks to the absence of debt.
What type of business is United-Guardian?
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
What sector is United-Guardian in?
United-Guardian is in the Consumer Defensive sector
What industry is United-Guardian in?
United-Guardian is in the Household & Personal Products industry
What country is United-Guardian from?
United-Guardian is headquartered in United States
When did United-Guardian go public?
United-Guardian initial public offering (IPO) was on 17 March 1980
What is United-Guardian website?
https://www.u-g.com
Is United-Guardian in the S&P 500?
No, United-Guardian is not included in the S&P 500 index
Is United-Guardian in the NASDAQ 100?
No, United-Guardian is not included in the NASDAQ 100 index
Is United-Guardian in the Dow Jones?
No, United-Guardian is not included in the Dow Jones index
When was United-Guardian the previous earnings report?
No data
When does United-Guardian earnings report?
The next expected earnings date for United-Guardian is 21 March 2025